ADMA Biologics Inc

23 wrz 2026, 21:01 UTC

ADMA Biologics Inc is trading lower in after-market hours, continuing a decline that began after Wednesday's close despite being above its 20-day moving average.

22 wrz 2026, 20:07 UTC

ADMA Biologics Inc is advancing during Tuesday's trading session, showing a steady upward trajectory and positioning well above its 20-day moving average.

21 wrz 2026, 20:01 UTC

ADMA Biologics Inc shares are rising, continuing an upward trend since Friday, with unusually high trading volume and a peak price reached today.

18 wrz 2026, 20:02 UTC

ADMA Biologics Inc is advancing, continuing a trend of higher movement since Thursday's close, amid a broader market backdrop of rising daily closes.

16 wrz 2026, 19:03 UTC

ADMA Biologics Inc is seeing notable upward movement on Wednesday, gaining ground since Tuesday's close, despite pulling back from a mid-afternoon peak.

15 wrz 2026, 20:01 UTC

ADMA Biologics Inc shares are lower today, influenced by a sharp decline in the NY Empire State Manufacturing Index and broader market sentiment.

14 wrz 2026, 20:07 UTC

ADMA Biologics Inc shares are lower, continuing a five-session decline amid broader concerns over rising crude oil prices and inflation ahead of the Fed's interest rate decision.

10 wrz 2026, 20:06 UTC

ADMA Biologics Inc shares are lower amid broader market declines and rising Treasury yields, reflecting three consecutive sessions of lower closes.

8 wrz 2026, 20:07 UTC

ADMA Biologics shares are lower as an investigation into potential fiduciary breaches by its Board of Directors is launched amid declining demand for ASCENIV.

28 sie 2026, 20:07 UTC

ADMA Biologics Inc shares are lower today, continuing a three-day decline. The stock remains significantly below its 20-day moving average amid rising Treasury yields.

27 sie 2026, 19:11 UTC

ADMA Biologics Inc. shares are lower today amid pressure on biotechnology stocks, despite a brief uptick earlier in the session. No specific news was identified.

26 sie 2026, 20:08 UTC

ADMA Biologics Inc. shares are lower amid biotechnology sector weakness, with no specific news identified to explain the decline.

25 sie 2026, 19:26 UTC

ADMA Biologics shares are higher today, supported by declining U.S. Treasury yields that typically enhance equity valuations. No specific company news was identified.

24 sie 2026, 20:06 UTC

ADMA Biologics Inc shares are lower during Monday's session, reversing earlier gains amid broader market influences, including rising oil prices and geopolitical tensions.

21 sie 2026, 23:01 UTC

ADMA Biologics Inc shares declined in after-market trading, continuing a trend of lower finishes over the past three sessions amid broader market volatility.

20 sie 2026, 20:06 UTC

ADMA Biologics Inc shares are lower in Thursday's session, with no specific news identified. Broader market declines may be influencing sentiment amid rising Treasury yields.

19 sie 2026, 20:01 UTC

ADMA Biologics Inc shares are higher Wednesday, continuing a strong upward trend since Tuesday's close, despite no specific news driving the move.

17 sie 2026, 19:36 UTC

ADMA Biologics is trading lower amid an investigation into potential fiduciary breaches by its Board of Directors. Broader market sentiment may also be impacting shares.

13 sie 2026, 20:02 UTC

ADMA Biologics shares are lower amid concerns over financial practices and potential SEC scrutiny, despite claims of an internal review clearing the company.

12 sie 2026, 19:46 UTC

ADMA Biologics shares are trading lower today, despite broader market gains following a positive inflation report. The stock remains near its one-month high.

11 sie 2026, 22:56 UTC

ADMA Biologics Inc shares are lower in after-market hours following an earlier decline. The price remains above its 20-day moving average.

7 sie 2026, 19:46 UTC

ADMA Biologics shares are lower following a securities fraud class action lawsuit alleging false statements and undisclosed transactions, amid broader negative market sentiment.

6 sie 2026, 20:02 UTC

ADMA Biologics reported second-quarter net income of $37.82 million and revenue of $124.40 million, driving shares higher during Thursday's session.

5 sie 2026, 23:02 UTC

ADMA Biologics reported second-quarter revenue of $124.4 million, missing expectations. Shares are lower in after-market trading following the earnings release.

4 sie 2026, 19:46 UTC

ADMA Biologics Inc. is trading higher, buoyed by strong momentum and a decline in crude oil prices that eases inflation concerns and supports consumer spending.

3 sie 2026, 19:16 UTC

ADMA Biologics Inc shares are higher today, continuing an upward trend since Friday amid broader market optimism following recent geopolitical developments.

31 lip 2026, 20:06 UTC

ADMA Biologics is declining amid a class action lawsuit alleging fraudulent activities, continuing a trend of four consecutive lower sessions.

30 lip 2026, 19:39 UTC

ADMA Biologics shares are lower following a decline in first-quarter performance, reflecting broader market sentiment amid ongoing investor concerns.

29 lip 2026, 18:17 UTC

ADMA Biologics will report second-quarter 2026 results on August 5, contributing to today's higher share price amid steady trading.

28 lip 2026, 20:06 UTC

ADMA Biologics Inc. is rising amid broader biotechnology sector strength, despite ongoing legal challenges. The stock has shown steady gains since Monday's close.